ANI PHARMACEUTICALS INC

By person

26 insiders · 264 transactions

28.7×

Nikhil Lalwani holds 28.7 times base salary in stock. $24.08M of shares against $837.41K in salary for 2025.

Salary from the company's own proxy. The shares are what Nikhil Lalwani last reported holding, valued at $71.00, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

$276.50K (2)

$58.70M (60) scheduled

−$58.43M

532,976

2.37%

$37.84M

—

MERIDIAN VENTURE PARTNERS II LP entity

10% owner

—

$28.62M (10)

−$28.62M

1,819,259

8.09%

$129.17M

−22.6%

Lalwani Nikhil

PRESIDENT & CEO

$200.00K (1)

$19.96M (11)

−$19.76M

339,089

1.51%

$24.08M

—

Gassert Chad

SVP - CORP. DEV. & STRATEGY

$275.09K (2)

$15.14M (13) scheduled

−$14.87M

233,406

1.04%

$16.57M

—

MARSHBANKS TRACY

Director

—

$12.49M (11)

−$12.49M

361,044

1.61%

$25.63M

−35.5%

CAREY STEPHEN P.

SVP & CFO

—

$8.41M (12) scheduled

−$8.41M

171,843

0.7640%

$12.20M

—

PRZYBYL ARTHUR

President and CEO

—

$7.80M (11)

−$7.80M

190,309

0.8461%

$13.51M

−12.1%

Marken James G.

SVP OPS & PROD DEV

—

$3.77M (7)

−$3.77M

117,829

0.5239%

$8.37M

+142.2%

Mutz Christopher

HEAD OF RARE DISEASE

—

$2.86M (11) scheduled

−$2.86M

91,309

0.4060%

$6.48M

—

Schrepfer Robert W

SVP - NEW BUS DEV & SPEC SALES

—

$2.70M (8) scheduled

−$2.70M

87,477

0.3889%

$6.21M

+403.8%

Gutwerg Ori

SVP, GENERICS

—

$2.68M (10)

−$2.68M

75,534

0.3358%

$5.36M

—

Walsh Patrick D

Director

$707.94K (6)

$3.12M (5)

−$2.42M

38,432

0.1709%

$2.73M

—

RAYNOR DANIEL

Director

—

$2.18M (6)

−$2.18M

300,113

1.33%

$21.31M

−10.2%

Thoma Jeanne

Director

$49.82K (1)

$1.99M (3)

−$1.94M

26,762

0.1190%

$1.90M

+1,684%

Pera Antonio R

Director

$126.79K (1)

$1.82M (4)

−$1.69M

27,017

0.1201%

$1.92M

—

Davis Krista

SVP, CHIEF HR OFFICER

—

$1.62M (12) scheduled

−$1.62M

51,946

0.2310%

$3.69M

—

HAUGHEY THOMAS

Director

$497.20K (4)

$1.82M (2)

−$1.33M

38,878

0.1729%

$2.76M

—

Cook Meredith

SR. VP, GENERAL COUNSEL & SEC.

—

$911.39K (35) scheduled

−$911.39K

73,924

0.3287%

$5.25M

—

Leonard Matthew J

Director

—

$840.72K (2)

−$840.72K

11,221

0.0499%

$796.69K

—

Rowland Thomas Andrew

SVP, HEAD - ESTABLISHED BRANDS

—

$820.24K (3)

−$820.24K

38,271

0.1702%

$2.72M

+9.6%

TANNENBAUM RENEE P

Director

—

$273.81K (2)

−$273.81K

29,514

0.1312%

$2.10M

—

NASH DAVID

Director

$99.36K (1)

—

+$99.36K

38,561

0.1714%

$2.74M

—

Brown Robert E. JR

Director

—

49,021

0.2180%

$3.48M

+384.9%

HOLUBOW FRED

Director

—

14,811

0.0659%

$1.05M

+25.4%

Penn Thomas A.

Director

—

14,301

0.0636%

$1.02M

+41.5%

Gosebruch Henry O

Director

—

6,662

0.0296%

$473.00K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

CAREY STEPHEN P.

2 Jul 2026

SVP & CFO

Sold after exercise

3,313

$86.00

$284.92K

CAREY STEPHEN P.

5 Jun 2026

SVP & CFO

Sold after exercise

3,312

$80.00

$264.96K

CAREY STEPHEN P.

5 Mar 2026

SVP & CFO

Sold after exercise

4,000

$75.56

$302.24K

CAREY STEPHEN P.

5 Mar 2026

SVP & CFO

Sold after exercise

3,312

$75.42

$249.79K

CAREY STEPHEN P.

12 Aug 2025

SVP & CFO

Sold after exercise

50,000

$86.07

$4.30M

Gutwerg Ori

5 Mar 2025

SVP, GENERICS

Sold after exercise

5,084

$60.00

$305.04K

Gutwerg Ori

5 Mar 2025

SVP, GENERICS

Sold after exercise

300

$60.03

$18.01K

Lalwani Nikhil

26 Nov 2024

PRESIDENT & CEO

Sold after exercise

3,481

$58.30

$202.94K

Lalwani Nikhil

26 Nov 2024

PRESIDENT & CEO

Sold after exercise

30,000

$57.95

$1.74M

Marken James G.

23 Aug 2023

SVP OPS & PROD DEV

Sold after exercise

3,932

$63.00

$247.72K

Gutwerg Ori

23 Aug 2023

SVP, GENERICS

Sold after exercise

2,059

$62.39

$128.46K

Gutwerg Ori

23 Aug 2023

SVP, GENERICS

Sold after exercise

13,502

$62.39

$842.39K

Lalwani Nikhil

15 Aug 2023

PRESIDENT & CEO

Sold after exercise

11,616

$61.13

$710.09K

PRZYBYL ARTHUR

19 Mar 2019

President and CEO

Sold after exercise

2,823

$63.51

$179.29K

PRZYBYL ARTHUR

18 Mar 2019

President and CEO

Sold after exercise

24,802

$63.53

$1.58M

Schrepfer Robert W

13 Mar 2019

SVP - New Bus Dev & Spec Sales

Sold after exercise

4,651

$64.43

$299.65K

Schrepfer Robert W

12 Mar 2019

SVP - New Bus Dev & Spec Sales

Sold after exercise

1,503

$64.50

$96.94K

Schrepfer Robert W

12 Mar 2019

SVP - New Bus Dev & Spec Sales

Sold after exercise

5,642

$64.44

$363.58K

Showing 250 of 264 transactions. The figures above use every one of them.

By person

Individual transactions

What was left out